Schilke Tobin
SEC insider (Form 3/4/5 filer). CIK 0001678984. Chief Financial & Infra. Ofcr. at Crinetics Pharmaceuticals, Inc. (CRNX) and 1 other issuer. 12 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in SAN DIEGO, CA.
Companies Schilke Tobin has filed insider reports for
- Crinetics Pharmaceuticals, Inc. (CRNX): Officer, Chief Financial & Infra. Ofcr.
- Revance Therapeutics, Inc. (RVNC): Officer, CFO
Schilke Tobin
CIK: 0001678984
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
DispositionDirect71.5K shares at avg. $85.00$6.1M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
DispositionDirect8K shares at avg. $85.00$676K - Aug 20, 2026CRNX
Crinetics Pharmaceuticals, Inc.
AwardDirect471 shares- - Mar 3, 2026CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect6.7K shares at avg. $39.67$266K - Feb 23, 2026CRNX
Crinetics Pharmaceuticals, Inc.
AwardDirect32K shares- - Mar 10, 2025CRNX
Crinetics Pharmaceuticals, Inc.
AwardDirect52K shares- - Feb 6, 2025RVNC
Revance Therapeutics, Inc.
DispositionDirect20.9K shares- - Feb 6, 2025RVNC
Revance Therapeutics, Inc.
AwardDirect20.9K shares- - Feb 6, 2025RVNC
Revance Therapeutics, Inc.
DispositionDirect103.6K shares- - Feb 4, 2025RVNC
Revance Therapeutics, Inc.
Tender OfferDirect98K shares at avg. $3.65$358K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 |  CRNX Crinetics Pharmaceuticals, Inc. | Disposition | 71,471 | $85.00 | $6,075,035 | Direct |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition | 7,956 | $85.00 | $676,260 | Direct |
| Aug 20, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Award | 471 | - | $0 | Direct |
| Mar 3, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 6,713 | $39.67 | $266,305 | Direct |
| Feb 23, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Award | 32,000 | - | $0 | Direct |
| Mar 10, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Award | 52,000 | - | - | Direct |
| Feb 6, 2025 |  RVNC Revance Therapeutics, Inc. | Disposition | 20,883 | - | - | Direct |
| Feb 6, 2025 | RVNC Revance Therapeutics, Inc. | Award | 20,883 | - | - | Direct |
| Feb 6, 2025 | RVNC Revance Therapeutics, Inc. | Disposition | 103,555 | - | - | Direct |
| Feb 4, 2025 | RVNC Revance Therapeutics, Inc. | Tender Offer | 97,999 | $3.65 | $357,696 | Direct |
1-10 of 12 transactions